In colon cancer cells treated with 5‐fluorouracil (5‐FU), high mGluR4 expression or agonist treatment promoted cell survival, whereas low mGluR4 expression or antagonist treatment had the opposite effect, indicating resistance to 5‐FU in cells with high mGluR4 levels [472]. This evidence concerns the gene GRM4 and colonic neoplasm.